Specifically, we deployed these combinational treatment regimens in transgenic mice that express human MUC1 (MUC1.Tg mice), and which were orthotopically injected with a murine syngeneic breast cancer cell line expressing human MUC1 (MTag.MUC1 cells). The gene discussed is MUC1; the disease is breast carcinoma.